CollabRx, U. of Chicago Medical Center Collaborate on NGS Data Interpretation | GenomeWeb

NEW YORK (GenomeWeb News) – CollabRx today announced a collaboration with the thoracic oncology program at the University of Chicago Medical Center for the interpretation of next-generation sequencing data from cancer mutation panels.

The collaboration will combine the results of cancer mutational panels conducted by researchers at the medical center with clinically actionable and "dynamically updated knowledge" from San Francisco-based CollabRx, including the clinical impact of specific mutational profiles and therapeutic strategies such as drugs and clinical trials.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.